Lucid Pharma Venlafaxine Capsules Recall: Melted Capsules Reported
Lucid Pharma recalls 75mg Venlafaxine Extended-Release Capsules due to reports of melted capsules in some bottles. This may affect safety and requires checking your product.
Lower-risk recall
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Contact the company
What happened, in plain English
Lucid Pharma is recalling 75mg Venlafaxine Hydrochloride Extended-Release Capsules that have been reported to contain melted capsules. This could lead to improper medication delivery and potential safety issues. Read more at govinfonow.com/recall/41588-lucid-pharma-venlafaxine-capsules-recall-melted-capsules-reported.
Source Summary by GovInfoNow · govinfonow.com/recall/41588-lucid-pharma-venlafaxine-capsules-recall-melted-capsules-reported · Updated October 8, 2026 · FDA enforcement record: FDA #D-0921-2017
Cite this page
“Lucid Pharma Venlafaxine Capsules Recall: Melted Capsules Reported.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41588-lucid-pharma-venlafaxine-capsules-recall-melted-capsules-reported. Based on FDA recall #D-0921-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0921-2017%22&limit=1).
Why it’s dangerous
Pharmacists have reported that some capsules in these bottles have melted. This could cause the medication to not be delivered properly, potentially leading to ineffective treatment.
Who’s affected
People who have the 30-count or 90-count bottles of 75mg Venlafaxine Extended-Release Capsules with specific lot numbers. Those taking this medication for depression or anxiety are most at risk.
How to tell if you have this one
Check for bottles labeled 30-count (NDC 52343-132-30) or 90-count (NDC 52343-132-90) with lot numbers V17516045-A (exp 08/18) or V17516047-A (exp 09/18).
- Brand
Lucid Pharma- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number and expiration date on the bottle to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0921-2017 (June 1, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0921-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.